Pharmacogenetics in Clinical Pediatrics: Challenges and Strategies

• Lasky T , ErnstFR, GreenspanJ. Use of analgesic, anesthetic, and sedative medications during pediatric hospitalizations in the United States 2008. Anesth. Analg.115(5) , 1155–1161 (2012).
   PubMed Web of Science ®Google Scholar
• Bartelink IH , WolfsT, JonkerM et al. Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients. Antimicrob. Agents Chemother. 57(1) , 235–240 (2013).
   PubMed Web of Science ®Google Scholar
• Guy-Viterbo V , ScohyA, VerbeeckRK, RedingR, WallemacqP, MusuambaFT. Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation. Eur. J. Clin. Pharmacol.69(8) , 1533–1542 (2013).
   PubMed Web of Science ®Google Scholar
• Ince I , de Wildt SN, Peeters MY et al. Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years. Ther. Drug Monit.34(4) , 381–389 (2012).
   PubMed Web of Science ®Google Scholar
• Lee JW , KangHJ, LeeSH et al. Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: Phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling. Biol. Blood Marrow Transplant 18(6) , 944–950 (2012).
   PubMed Web of Science ®Google Scholar
• Williams JH , JayaramanB, SwobodaKJ, BarrettJS. Population pharmacokinetics of valproic acid in pediatric patients with epilepsy: considerations for dosing spinal muscular atrophy patients. J. Clin. Pharmacol.52(11) , 1676–1688 (2012).
   PubMed Web of Science ®Google Scholar
• Leeder JS . Pharmacogenetics and pharmacogenomics. Pediatr. Clin. North Am.48(3) , 765–781 (2001).
   PubMed Web of Science ®Google Scholar
• Wagner J , LeederJS. Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children. Pediatr. Clin. North Am.59(5) , 1017–1037 (2012).
   PubMed Web of Science ®Google Scholar
• Alcorn J , McNamaraPJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin. Pharmacokinet.41(12) , 959–998 (2002).
   PubMed Web of Science ®Google Scholar
• Blake MJ , CastroL, LeederJS, KearnsGL. Ontogeny of drug-metabolizing enzymes in the neonate. Semin. Fetal Neonatal Med.10(2) , 123–138 (2005).
   PubMed Web of Science ®Google Scholar
• Bouwmeester NJ , van den Anker JN, Hop WC, Anand KJ, Tibboel D. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants. Br. J. Anaesth.90(5) , 642–652 (2003).
   PubMed Web of Science ®Google Scholar
• de Wildt SN , KearnsGL, LeederJS, van den Anker JN. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin. Pharmacokinet.36(6) , 439–452 (1999).
   PubMed Web of Science ®Google Scholar
• Wilke RA , RamseyLB, JohnsonSG et al. The Clinical Pharmacogenomics Implementation Consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin. Pharmacol. Ther. 92(1) , 112–117 (2012).
   PubMed Web of Science ®Google Scholar
• Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics128(Suppl. 5) , S213–S256 (2011).
   PubMed Web of Science ®Google Scholar
• Hedman M , AntikainenM, HolmbergC et al. Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes. Br. J. Clin. Pharmacol. 61(6) , 706–715 (2006).
   PubMed Web of Science ®Google Scholar
• McCrindle BW , UrbinaEM, DennisonBA et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115(14) , 1948–1967 (2007).
   PubMed Web of Science ®Google Scholar
• Friedman WF , HirschklauMJ, PrintzMP, PitlickPT, KirkpatrickSE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N. Engl. J. Med.295(10) , 526–529 (1976).
   PubMed Web of Science ®Google Scholar
• Heymann MA , RudolphAM, SilvermanNH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N. Engl. J. Med.295(10) , 530–533 (1976).
   PubMed Web of Science ®Google Scholar
• Hirt D , Van Overmeire B, Treluyer J-M et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br. J. Clin. Pharmacol.65(5) , 629–636 (2008).
   PubMed Web of Science ®Google Scholar
• Van vermeire O B, Touw D, Schepens PJ, Kearns GL, van den Anker JN. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin. Pharmacol. Ther.70(4) , 336–343 (2001).
   PubMed Web of Science ®Google Scholar
• Reese J , VeldmanA, ShahL, VucovichM, CottonRB. Inadvertent relaxation of the ductus arteriosus by pharmacological agents that are commonly used in the neonatal period. Semin. Perinatol.34(3) , 222–230 (2010).
   PubMed Web of Science ®Google Scholar
• Ervens J , SchiffmannL, BergerG, HoffmeisterB. Colon perforation with acute peritonitis after taking clindamycin and diclofenac following wisdom tooth removal. J. Craniomaxillofac. Surg.32(5) , 330–334 (2004).
   PubMed Web of Science ®Google Scholar
• Kara C , DericiH, NazliO, TansugT, BozdagAD. Colonic perforation after short-term use of nonsteroidal antiinflammatory drugs: report of two cases. Tech. Coloproctol.13(1) , 75–78 (2009).
   PubMed Web of Science ®Google Scholar
• Wadhawan R , OhW, VohrBR et al. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age. Arch. Dis. Child Fetal Neonatal Ed. 98(2) , F127–F132 (2013).
   PubMed Web of Science ®Google Scholar
• Clyman R , WickremasingheA, JhaveriN et al. Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus. J. Pediatr. 163(2) , 406–411.e4 (2013).
   PubMed Web of Science ®Google Scholar
• Fallat ME , KatzAL, MercurioMR et al. Ethical and policy issues in genetic testing and screening of children. Pediatrics 131(3) , 620–622 (2013).
   PubMed Web of Science ®Google Scholar
• Ross LF , SaalHM, DavidKL, Anderson RR; American Academy of Pediatrics; American College of Medical Genetics and Genomics. Technical report: ethical and policy issues in genetic testing and screening of children. Genet. Med.15(3) , 234–245 (2013).
   PubMedGoogle Scholar
• Madadi P , RossCJ, HaydenMR et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin. Pharmacol. Ther. 85(1) , 31–35 (2009).
   PubMed Web of Science ®Google Scholar
• Vandervaart S , BergerH, SistonenJ et al. CYP2D6 Polymorphisms and codeine analgesia in postpartum pain management: a pilot study. Ther. Drug Monit.33(4) , 425–432 (2011).
   PubMed Web of Science ®Google Scholar
• Klein TE , AltmanRB, ErikssonN et al.; International Warfarin Pharmacogenetics Consortium. The International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med.360(8) , 753–764 (2009).
   PubMed Web of Science ®Google Scholar
• Wadelius M , ChenLY, LindhJD et al. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 113(4) , 784–792 (2009).
   PubMed Web of Science ®Google Scholar
• Epstein RS , MoyerTP, AubertRE et al. Warfarin genotyping reduces hospitalization rates: results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study). J. Am. Coll. Cardiol. 55(25) , 2804–2812 (2010).
   PubMed Web of Science ®Google Scholar
• Hirai K , HayashiH, OnoY et al. Influence of CYP4F2 polymorphisms and plasma vitamin K levels on warfarin sensitivity in Japanese pediatric patients. Drug Metab. Pharmacokinet. 28(2) , 132–137 (2013).
   PubMed Web of Science ®Google Scholar
• Biss TT , AveryPJ, BrandãoLR et al. VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. Blood119(3) , 868–873 (2012).
   PubMed Web of Science ®Google Scholar
• Johnson JA , GongL, Whirl-CarrilloM et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin. Pharmacol. Ther. 90(4) , 625–629 (2011).
   PubMed Web of Science ®Google Scholar
• Kato Y , IchidaF, SaitoK et al. Effect of the VKORC1 genotype on warfarin dose requirements in Japanese pediatric patients. Drug Metab. Pharmacokinet. 26(3) , 295–299 (2011).
   PubMed Web of Science ®Google Scholar
• Kosaki K , YamaghishiC, SatoR et al. 1173C>T polymorphism in VKORC1 modulates the required warfarin dose. Pediatr. Cardiol. 27(6) , 685–688 (2006).
   PubMed Web of Science ®Google Scholar
• Moreau C , BajolleF, SiguretV et al. Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement. Blood 119(3) , 861–867 (2012).
   PubMed Web of Science ®Google Scholar
• Nguyen N , AnleyP, YuMY, ZhangG, ThompsonAA, JenningsLJ. Genetic and clinical determinants influencing warfarin dosing in children with heart disease. Pediatr. Cardiol.34(4) , 984–990 (2013).
   PubMed Web of Science ®Google Scholar
• Nowak -Göttl U , DietrichK, SchaffranekD et al. In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes. Blood 116(26) , 6101–6105 (2010).
   PubMed Web of Science ®Google Scholar
• Do EJ , LenziniP, EbyCS et al. Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design. Pharmacogenomics J. 12(5) , 417–424 (2012).
   PubMed Web of Science ®Google Scholar
• French B , JooJ, GellerNL et al. Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial. Trials 11 , 108 (2010).
   PubMed Web of Science ®Google Scholar
• Johnson TN , Rostami-HodjeganA, TuckerGT. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin. Pharmacokinet.45(9) , 931–956 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson TN , Rostami-HodjeganA. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Paediatr. Anaesth.21(3) , 291–301 (2011).
   PubMed Web of Science ®Google Scholar
• Harris LF , RaineyP, Castro-LópezV, O‘DonnellJS, KillardAJ. A microfluidic anti-Factor Xa assay device for point of care monitoring of anticoagulation therapy. Analyst138(17) , 4769–4776 (2013).
   PubMed Web of Science ®Google Scholar
• Li CG , LeeCY, LeeK, JungH. An optimized hollow microneedle for minimally invasive blood extraction. Biomed Microdevices.15(1) , 17–25 (2013).
   PubMed Web of Science ®Google Scholar
• Li T , BarnettA, RogersKL, GianchandaniYB. A blood sampling microsystem for pharmacokinetic applications: design, fabrication, and initial results. Lab. Chip.9(24) , 3495–3503 (2009).
   PubMed Web of Science ®Google Scholar
• Shah NM , HawwaAF, MillershipJS, CollierPS, McElnayJC. A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.923–924 , 65–73 (2013).
   PubMed Web of Science ®Google Scholar
• Shan Z , ZhouZ, ChenH et al. PCR-ready human DNA extraction from urine samples using magnetic nanoparticles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 881–882 , 63–68 (2012).
   PubMed Web of Science ®Google Scholar
• Hawwa AF , CollierPS, MillershipJS et al. Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia. Br. J. Clin. Pharmacol. 66(6) , 826–837 (2008).
   PubMed Web of Science ®Google Scholar
• Suyagh M , CollierPS, MillershipJS et al. Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics 127(2) , e367–e374 (2011).
   PubMed Web of Science ®Google Scholar
• McCarty CA , ChisholmRL, ChuteCG et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genomics. 4 , 13 (2011).
   PubMed Web of Science ®Google Scholar
• Freund CL , ClaytonEW. Pharmacogenomics and children: meeting the ethical challenges. Am. J. Pharmacogenomics.3(6) , 399–404 (2003).
   PubMedGoogle Scholar
• Moran C , ThornburgCD, BarfieldRC. Ethical considerations for pharmacogenomic testing in pediatric clinical care and research. Pharmacogenomics12(6) , 889–895 (2011).
   PubMed Web of Science ®Google Scholar
• Tabor HK , BrazgT, CrouchJ et al. Parent perspectives on pediatric genetic research and implications for genotype-driven research recruitment. J. Empir. Res. Hum. Res. Ethics 6(4) , 41–52 (2011).
   PubMed Web of Science ®Google Scholar
• Harris ED , ZinielSI, AmatrudaJG et al. The beliefs, motivations, and expectations of parents who have enrolled their children in a genetic biorepository. Genet. Med. 14(3) , 330–337 (2012).
   PubMed Web of Science ®Google Scholar

▪ Websites

• Products – Data Briefs – Number 42. September 2010. www.cdc.gov/nchs/data/databriefs/db42.htm#fig3
   Google Scholar
• Best Pharmaceuticals for Children Act. Public Law No. 107–109, 115 Stat. 1408 (2002). www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ucm148011.htm
   Google Scholar
• PharmGBK. CPIC Dosing Guideline for simvastatin and SLCO1B1. www.pharmgkb.org/gene/PA134865839
   Google Scholar
• Drugs@FDA. www.accessdata.fda.gov/scripts/cder/drugsatfda
   Google Scholar